nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxychloroquine—CYP2D6—Tamoxifen—pancreatic cancer	0.00886	0.44	CbGbCtD
Hydroxychloroquine—CYP2D6—Erlotinib—pancreatic cancer	0.00753	0.374	CbGbCtD
Hydroxychloroquine—Chloroquine—TNF—pancreatic cancer	0.00409	1	CrCbGaD
Hydroxychloroquine—CYP2D6—Doxorubicin—pancreatic cancer	0.00371	0.185	CbGbCtD
Hydroxychloroquine—TLR9—IRS-mediated signalling—TSC2—pancreatic cancer	0.00288	0.00974	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—NFKBIA—pancreatic cancer	0.00288	0.00971	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—TSC2—pancreatic cancer	0.00281	0.00948	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—PIK3CG—pancreatic cancer	0.00279	0.00941	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—TSC2—pancreatic cancer	0.00278	0.00939	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IFNA2—pancreatic cancer	0.00272	0.0092	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—TSC2—pancreatic cancer	0.00271	0.00914	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—TSC2—pancreatic cancer	0.00271	0.00914	CbGpPWpGaD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NFKBIA—pancreatic cancer	0.00261	0.0088	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—NFKBIA—pancreatic cancer	0.00256	0.00864	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—NFKBIA—pancreatic cancer	0.00247	0.00834	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—PIK3CD—pancreatic cancer	0.00245	0.00827	CbGpPWpGaD
Hydroxychloroquine—TLR9—PI3K Cascade—PIK3CB—pancreatic cancer	0.00233	0.00788	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—NFKBIA—pancreatic cancer	0.00227	0.00768	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—TSC2—pancreatic cancer	0.00225	0.0076	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—NFKBIA—pancreatic cancer	0.00225	0.00758	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—NFKBIA—pancreatic cancer	0.00222	0.0075	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—PIK3CG—pancreatic cancer	0.0022	0.00744	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—PIK3CG—pancreatic cancer	0.00217	0.00734	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—IFNA5—pancreatic cancer	0.00216	0.0073	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—PIK3CB—pancreatic cancer	0.00213	0.00721	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—DTX4—pancreatic cancer	0.0021	0.00709	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—CXCL8—pancreatic cancer	0.00205	0.00693	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—PIK3CB—pancreatic cancer	0.00195	0.00659	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—PIK3CD—pancreatic cancer	0.00194	0.00654	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—PIK3CD—pancreatic cancer	0.00191	0.00646	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—PIK3CB—pancreatic cancer	0.0019	0.00641	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—PIK3CB—pancreatic cancer	0.00188	0.00635	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—PIK3CB—pancreatic cancer	0.00183	0.00619	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—PIK3CB—pancreatic cancer	0.00183	0.00619	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—NFKBIA—pancreatic cancer	0.00178	0.00599	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—NFKBIA—pancreatic cancer	0.00175	0.00593	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—PIK3CG—pancreatic cancer	0.00172	0.00581	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—RAP1GAP—pancreatic cancer	0.00172	0.0058	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—IFNA5—pancreatic cancer	0.00171	0.00577	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—PIK3CB—pancreatic cancer	0.00169	0.0057	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—PIK3CB—pancreatic cancer	0.00167	0.00563	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—DTX4—pancreatic cancer	0.00166	0.00561	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—CXCL8—pancreatic cancer	0.00162	0.00548	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—CXCL8—pancreatic cancer	0.0016	0.00541	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—PIK3CB—pancreatic cancer	0.00152	0.00514	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—PIK3CD—pancreatic cancer	0.00151	0.0051	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—NRAS—pancreatic cancer	0.00151	0.00508	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—NRAS—pancreatic cancer	0.00146	0.00494	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—NRAS—pancreatic cancer	0.00145	0.0049	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—TNF—pancreatic cancer	0.00143	0.00482	CbGpPWpGaD
Hydroxychloroquine—TLR9—PI3K Cascade—PIK3CA—pancreatic cancer	0.00142	0.0048	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—NRAS—pancreatic cancer	0.00141	0.00477	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—NRAS—pancreatic cancer	0.00141	0.00477	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—GDI2—pancreatic cancer	0.00136	0.0046	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—GDI1—pancreatic cancer	0.00136	0.0046	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—RAP1GAP—pancreatic cancer	0.00136	0.00458	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—PIK3CB—pancreatic cancer	0.00132	0.00445	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—PIK3CA—pancreatic cancer	0.0013	0.00439	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—KRAS—pancreatic cancer	0.0013	0.00437	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—CXCL8—pancreatic cancer	0.00127	0.00427	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—KRAS—pancreatic cancer	0.00126	0.00425	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IFNA5—pancreatic cancer	0.00126	0.00425	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—KRAS—pancreatic cancer	0.00125	0.00422	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—DTX4—pancreatic cancer	0.00122	0.00413	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—KRAS—pancreatic cancer	0.00122	0.00411	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—KRAS—pancreatic cancer	0.00122	0.00411	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—PIK3CA—pancreatic cancer	0.00119	0.00402	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PPP2R5B—pancreatic cancer	0.00119	0.00402	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—IFNA1—pancreatic cancer	0.00119	0.004	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—NRAS—pancreatic cancer	0.00117	0.00396	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—PIK3CA—pancreatic cancer	0.00116	0.00391	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—PIK3CA—pancreatic cancer	0.00115	0.00387	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—TNF—pancreatic cancer	0.00113	0.00381	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—PIK3CA—pancreatic cancer	0.00112	0.00377	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—PIK3CA—pancreatic cancer	0.00112	0.00377	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—TNF—pancreatic cancer	0.00111	0.00376	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—IFNA2—pancreatic cancer	0.0011	0.00373	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—HRAS—pancreatic cancer	0.0011	0.00372	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—HRAS—pancreatic cancer	0.00107	0.00362	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—AKT1—pancreatic cancer	0.00106	0.00359	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—HRAS—pancreatic cancer	0.00106	0.00358	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—HRAS—pancreatic cancer	0.00103	0.00349	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—HRAS—pancreatic cancer	0.00103	0.00349	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—PIK3CA—pancreatic cancer	0.00103	0.00347	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—PIK3CA—pancreatic cancer	0.00102	0.00343	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—KRAS—pancreatic cancer	0.00101	0.00341	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Melatonin metabolism and effects—APOE—pancreatic cancer	0.001	0.00339	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IFNA5—pancreatic cancer	0.000996	0.00336	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—DTX4—pancreatic cancer	0.000967	0.00326	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PPP2R5B—pancreatic cancer	0.00094	0.00318	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—IFNA1—pancreatic cancer	0.000937	0.00316	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—PIK3CA—pancreatic cancer	0.000928	0.00313	CbGpPWpGaD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000918	0.00135	CcSEcCtD
Hydroxychloroquine—Asthenia—Erlotinib—pancreatic cancer	0.000915	0.00135	CcSEcCtD
Hydroxychloroquine—Dermatitis exfoliative—Epirubicin—pancreatic cancer	0.000914	0.00135	CcSEcCtD
Hydroxychloroquine—Hepatic function abnormal—Doxorubicin—pancreatic cancer	0.000913	0.00134	CcSEcCtD
Hydroxychloroquine—Pruritus—Tamoxifen—pancreatic cancer	0.000912	0.00134	CcSEcCtD
Hydroxychloroquine—Oedema—Irinotecan—pancreatic cancer	0.000909	0.00134	CcSEcCtD
Hydroxychloroquine—Photosensitivity—Doxorubicin—pancreatic cancer	0.000909	0.00134	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000903	0.00133	CcSEcCtD
Hydroxychloroquine—Dermatitis bullous—Epirubicin—pancreatic cancer	0.000903	0.00133	CcSEcCtD
Hydroxychloroquine—Pruritus—Erlotinib—pancreatic cancer	0.000902	0.00133	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Irinotecan—pancreatic cancer	0.000892	0.00131	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00089	0.00131	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Docetaxel—pancreatic cancer	0.000889	0.00131	CcSEcCtD
Hydroxychloroquine—Oedema—Gemcitabine—pancreatic cancer	0.000886	0.0013	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Docetaxel—pancreatic cancer	0.000885	0.0013	CcSEcCtD
Hydroxychloroquine—Cardiac failure—Epirubicin—pancreatic cancer	0.000884	0.0013	CcSEcCtD
Hydroxychloroquine—Hypoglycaemia—Epirubicin—pancreatic cancer	0.000884	0.0013	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Tamoxifen—pancreatic cancer	0.000882	0.0013	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TNF—pancreatic cancer	0.000881	0.00298	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PRLHR—pancreatic cancer	0.000877	0.00296	CbGpPWpGaD
Hydroxychloroquine—Body temperature increased—Sunitinib—pancreatic cancer	0.000873	0.00128	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Sunitinib—pancreatic cancer	0.000873	0.00128	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Erlotinib—pancreatic cancer	0.000873	0.00128	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—IFNA2—pancreatic cancer	0.000872	0.00294	CbGpPWpGaD
Hydroxychloroquine—Oedema—Fluorouracil—pancreatic cancer	0.000871	0.00128	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000869	0.00128	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000867	0.00128	CcSEcCtD
Hydroxychloroquine—Anorexia—Irinotecan—pancreatic cancer	0.000867	0.00128	CcSEcCtD
Hydroxychloroquine—Skin disorder—Gemcitabine—pancreatic cancer	0.00086	0.00127	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—HRAS—pancreatic cancer	0.000859	0.0029	CbGpPWpGaD
Hydroxychloroquine—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000854	0.00126	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000853	0.00125	CcSEcCtD
Hydroxychloroquine—Visual impairment—Docetaxel—pancreatic cancer	0.000853	0.00125	CcSEcCtD
Hydroxychloroquine—Dizziness—Tamoxifen—pancreatic cancer	0.000852	0.00125	CcSEcCtD
Hydroxychloroquine—Affect lability—Epirubicin—pancreatic cancer	0.000849	0.00125	CcSEcCtD
Hydroxychloroquine—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.000846	0.00124	CcSEcCtD
Hydroxychloroquine—Anorexia—Gemcitabine—pancreatic cancer	0.000844	0.00124	CcSEcCtD
Hydroxychloroquine—Dizziness—Erlotinib—pancreatic cancer	0.000843	0.00124	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—AKT1—pancreatic cancer	0.00084	0.00284	CbGpPWpGaD
Hydroxychloroquine—Erythema multiforme—Docetaxel—pancreatic cancer	0.000837	0.00123	CcSEcCtD
Hydroxychloroquine—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.000835	0.00123	CcSEcCtD
Hydroxychloroquine—Anorexia—Fluorouracil—pancreatic cancer	0.00083	0.00122	CcSEcCtD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—AKT1—pancreatic cancer	0.00083	0.0028	CbGpPWpGaD
Hydroxychloroquine—Eye disorder—Docetaxel—pancreatic cancer	0.000827	0.00122	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—ACVR1B—pancreatic cancer	0.000825	0.00279	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ZNRF3—pancreatic cancer	0.000825	0.00279	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Tamoxifen—pancreatic cancer	0.00082	0.00121	CcSEcCtD
Hydroxychloroquine—Cardiac failure—Doxorubicin—pancreatic cancer	0.000818	0.0012	CcSEcCtD
Hydroxychloroquine—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.000818	0.0012	CcSEcCtD
Hydroxychloroquine—Mood swings—Epirubicin—pancreatic cancer	0.000817	0.0012	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Sunitinib—pancreatic cancer	0.000813	0.0012	CcSEcCtD
Hydroxychloroquine—Rash—Tamoxifen—pancreatic cancer	0.000813	0.0012	CcSEcCtD
Hydroxychloroquine—Dermatitis—Tamoxifen—pancreatic cancer	0.000812	0.00119	CcSEcCtD
Hydroxychloroquine—Ataxia—Epirubicin—pancreatic cancer	0.000811	0.00119	CcSEcCtD
Hydroxychloroquine—Vomiting—Erlotinib—pancreatic cancer	0.000811	0.00119	CcSEcCtD
Hydroxychloroquine—Somnolence—Irinotecan—pancreatic cancer	0.000808	0.00119	CcSEcCtD
Hydroxychloroquine—Headache—Tamoxifen—pancreatic cancer	0.000807	0.00119	CcSEcCtD
Hydroxychloroquine—Rash—Erlotinib—pancreatic cancer	0.000804	0.00118	CcSEcCtD
Hydroxychloroquine—Dermatitis—Erlotinib—pancreatic cancer	0.000803	0.00118	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—PIK3CA—pancreatic cancer	0.000803	0.00271	CbGpPWpGaD
Hydroxychloroquine—Headache—Erlotinib—pancreatic cancer	0.000799	0.00118	CcSEcCtD
Hydroxychloroquine—Liver function test abnormal—Epirubicin—pancreatic cancer	0.000796	0.00117	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—BCL2L1—pancreatic cancer	0.000793	0.00268	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Sunitinib—pancreatic cancer	0.000792	0.00117	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Irinotecan—pancreatic cancer	0.000791	0.00116	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—TSC2—pancreatic cancer	0.000789	0.00266	CbGpPWpGaD
Hydroxychloroquine—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000788	0.00116	CcSEcCtD
Hydroxychloroquine—Somnolence—Gemcitabine—pancreatic cancer	0.000787	0.00116	CcSEcCtD
Hydroxychloroquine—Affect lability—Doxorubicin—pancreatic cancer	0.000786	0.00116	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000785	0.00116	CcSEcCtD
Hydroxychloroquine—Fatigue—Irinotecan—pancreatic cancer	0.000784	0.00115	CcSEcCtD
Hydroxychloroquine—Alopecia—Docetaxel—pancreatic cancer	0.000782	0.00115	CcSEcCtD
Hydroxychloroquine—Pruritus—Sunitinib—pancreatic cancer	0.000781	0.00115	CcSEcCtD
Hydroxychloroquine—Pain—Irinotecan—pancreatic cancer	0.000778	0.00114	CcSEcCtD
Hydroxychloroquine—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000777	0.00114	CcSEcCtD
Hydroxychloroquine—Mental disorder—Docetaxel—pancreatic cancer	0.000775	0.00114	CcSEcCtD
Hydroxychloroquine—Somnolence—Fluorouracil—pancreatic cancer	0.000774	0.00114	CcSEcCtD
Hydroxychloroquine—Malnutrition—Docetaxel—pancreatic cancer	0.00077	0.00113	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Gemcitabine—pancreatic cancer	0.00077	0.00113	CcSEcCtD
Hydroxychloroquine—Nausea—Tamoxifen—pancreatic cancer	0.000766	0.00113	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000765	0.00113	CcSEcCtD
Hydroxychloroquine—Fatigue—Gemcitabine—pancreatic cancer	0.000764	0.00112	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Epirubicin—pancreatic cancer	0.000761	0.00112	CcSEcCtD
Hydroxychloroquine—Pain—Gemcitabine—pancreatic cancer	0.000758	0.00111	CcSEcCtD
Hydroxychloroquine—Nausea—Erlotinib—pancreatic cancer	0.000758	0.00111	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000757	0.00111	CcSEcCtD
Hydroxychloroquine—Mood swings—Doxorubicin—pancreatic cancer	0.000756	0.00111	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Sunitinib—pancreatic cancer	0.000755	0.00111	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000752	0.00111	CcSEcCtD
Hydroxychloroquine—Ataxia—Doxorubicin—pancreatic cancer	0.000751	0.0011	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—SSTR3—pancreatic cancer	0.000746	0.00252	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—DTX1—pancreatic cancer	0.000746	0.00252	CbGpPWpGaD
Hydroxychloroquine—Pain—Fluorouracil—pancreatic cancer	0.000745	0.0011	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000744	0.00109	CcSEcCtD
Hydroxychloroquine—Eosinophilia—Epirubicin—pancreatic cancer	0.000738	0.00109	CcSEcCtD
Hydroxychloroquine—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000737	0.00108	CcSEcCtD
Hydroxychloroquine—Dizziness—Sunitinib—pancreatic cancer	0.00073	0.00107	CcSEcCtD
Hydroxychloroquine—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000729	0.00107	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—NFKBIA—pancreatic cancer	0.000719	0.00243	CbGpPWpGaD
Hydroxychloroquine—Abdominal pain—Irinotecan—pancreatic cancer	0.000719	0.00106	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Irinotecan—pancreatic cancer	0.000719	0.00106	CcSEcCtD
Hydroxychloroquine—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000719	0.00106	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—SSTR1—pancreatic cancer	0.000715	0.00241	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CD44—pancreatic cancer	0.000713	0.00241	CbGpPWpGaD
Hydroxychloroquine—Anaemia—Docetaxel—pancreatic cancer	0.000712	0.00105	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Epirubicin—pancreatic cancer	0.000708	0.00104	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Doxorubicin—pancreatic cancer	0.000704	0.00104	CcSEcCtD
Hydroxychloroquine—Vomiting—Sunitinib—pancreatic cancer	0.000702	0.00103	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—PPY—pancreatic cancer	0.000701	0.00237	CbGpPWpGaD
Hydroxychloroquine—Body temperature increased—Gemcitabine—pancreatic cancer	0.0007	0.00103	CcSEcCtD
Hydroxychloroquine—Rash—Sunitinib—pancreatic cancer	0.000696	0.00102	CcSEcCtD
Hydroxychloroquine—Dermatitis—Sunitinib—pancreatic cancer	0.000695	0.00102	CcSEcCtD
Hydroxychloroquine—Urticaria—Fluorouracil—pancreatic cancer	0.000692	0.00102	CcSEcCtD
Hydroxychloroquine—Headache—Sunitinib—pancreatic cancer	0.000692	0.00102	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—IFNA1—pancreatic cancer	0.00069	0.00233	CbGpPWpGaD
Hydroxychloroquine—Leukopenia—Docetaxel—pancreatic cancer	0.000689	0.00101	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000689	0.00101	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—EGF—pancreatic cancer	0.000688	0.00232	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SSTR2—pancreatic cancer	0.000688	0.00232	CbGpPWpGaD
Hydroxychloroquine—Eosinophilia—Doxorubicin—pancreatic cancer	0.000683	0.001	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000681	0.001	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000677	0.000996	CcSEcCtD
Hydroxychloroquine—Weight decreased—Epirubicin—pancreatic cancer	0.000675	0.000992	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Irinotecan—pancreatic cancer	0.00067	0.000986	CcSEcCtD
Hydroxychloroquine—Convulsion—Docetaxel—pancreatic cancer	0.000667	0.000982	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—CCKBR—pancreatic cancer	0.000665	0.00225	CbGpPWpGaD
Hydroxychloroquine—Drowsiness—Epirubicin—pancreatic cancer	0.000665	0.000978	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000659	0.00097	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—AKT1—pancreatic cancer	0.000656	0.00222	CbGpPWpGaD
Hydroxychloroquine—Nausea—Sunitinib—pancreatic cancer	0.000656	0.000965	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Doxorubicin—pancreatic cancer	0.000655	0.000964	CcSEcCtD
Hydroxychloroquine—Asthenia—Irinotecan—pancreatic cancer	0.000652	0.00096	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000651	0.000958	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—IFNA2—pancreatic cancer	0.000642	0.00217	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000642	0.000944	CcSEcCtD
Hydroxychloroquine—Asthenia—Gemcitabine—pancreatic cancer	0.000636	0.000935	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.00063	0.000927	CcSEcCtD
Hydroxychloroquine—Oedema—Docetaxel—pancreatic cancer	0.000629	0.000925	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—BCL2L1—pancreatic cancer	0.000627	0.00212	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Gemcitabine—pancreatic cancer	0.000627	0.000922	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—DTX4—pancreatic cancer	0.000625	0.00211	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—GLI1—pancreatic cancer	0.000625	0.00211	CbGpPWpGaD
Hydroxychloroquine—Weight decreased—Doxorubicin—pancreatic cancer	0.000624	0.000918	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—TSC2—pancreatic cancer	0.000623	0.00211	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Irinotecan—pancreatic cancer	0.000622	0.000915	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Epirubicin—pancreatic cancer	0.00062	0.000913	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Docetaxel—pancreatic cancer	0.000616	0.000907	CcSEcCtD
Hydroxychloroquine—Pruritus—Fluorouracil—pancreatic cancer	0.000616	0.000907	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000615	0.000906	CcSEcCtD
Hydroxychloroquine—Drowsiness—Doxorubicin—pancreatic cancer	0.000615	0.000905	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—PIK3CD—pancreatic cancer	0.000612	0.00207	CbGpPWpGaD
Hydroxychloroquine—Skin disorder—Docetaxel—pancreatic cancer	0.000611	0.000898	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.00061	0.000897	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—NRP1—pancreatic cancer	0.000608	0.00205	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000608	0.00205	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000606	0.000892	CcSEcCtD
Hydroxychloroquine—Dizziness—Irinotecan—pancreatic cancer	0.000601	0.000885	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Epirubicin—pancreatic cancer	0.0006	0.000883	CcSEcCtD
Hydroxychloroquine—Anorexia—Docetaxel—pancreatic cancer	0.000599	0.000882	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Epirubicin—pancreatic cancer	0.000597	0.000878	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000596	0.000877	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—HEY2—pancreatic cancer	0.000585	0.00198	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Irinotecan—pancreatic cancer	0.000578	0.000851	CcSEcCtD
Hydroxychloroquine—Dizziness—Fluorouracil—pancreatic cancer	0.000576	0.000847	CcSEcCtD
Hydroxychloroquine—Visual impairment—Epirubicin—pancreatic cancer	0.000575	0.000846	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000574	0.000845	CcSEcCtD
Hydroxychloroquine—Rash—Irinotecan—pancreatic cancer	0.000573	0.000844	CcSEcCtD
Hydroxychloroquine—Dermatitis—Irinotecan—pancreatic cancer	0.000573	0.000843	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—GAST—pancreatic cancer	0.000572	0.00193	CbGpPWpGaD
Hydroxychloroquine—Headache—Irinotecan—pancreatic cancer	0.00057	0.000838	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—NFKBIA—pancreatic cancer	0.000568	0.00192	CbGpPWpGaD
Hydroxychloroquine—Erythema multiforme—Epirubicin—pancreatic cancer	0.000564	0.00083	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CD44—pancreatic cancer	0.000563	0.0019	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Gemcitabine—pancreatic cancer	0.000563	0.000829	CcSEcCtD
Hydroxychloroquine—Somnolence—Docetaxel—pancreatic cancer	0.000559	0.000822	CcSEcCtD
Hydroxychloroquine—Rash—Gemcitabine—pancreatic cancer	0.000559	0.000822	CcSEcCtD
Hydroxychloroquine—Dermatitis—Gemcitabine—pancreatic cancer	0.000558	0.000821	CcSEcCtD
Hydroxychloroquine—Eye disorder—Epirubicin—pancreatic cancer	0.000558	0.000821	CcSEcCtD
Hydroxychloroquine—Tinnitus—Epirubicin—pancreatic cancer	0.000556	0.000819	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Doxorubicin—pancreatic cancer	0.000555	0.000817	CcSEcCtD
Hydroxychloroquine—Headache—Gemcitabine—pancreatic cancer	0.000555	0.000816	CcSEcCtD
Hydroxychloroquine—Vomiting—Fluorouracil—pancreatic cancer	0.000554	0.000815	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Doxorubicin—pancreatic cancer	0.000552	0.000812	CcSEcCtD
Hydroxychloroquine—Rash—Fluorouracil—pancreatic cancer	0.000549	0.000808	CcSEcCtD
Hydroxychloroquine—Dermatitis—Fluorouracil—pancreatic cancer	0.000549	0.000807	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Docetaxel—pancreatic cancer	0.000546	0.000804	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—IFNA1—pancreatic cancer	0.000546	0.00184	CbGpPWpGaD
Hydroxychloroquine—Headache—Fluorouracil—pancreatic cancer	0.000546	0.000803	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—EGF—pancreatic cancer	0.000544	0.00184	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000543	0.000798	CcSEcCtD
Hydroxychloroquine—Fatigue—Docetaxel—pancreatic cancer	0.000542	0.000797	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—SCT—pancreatic cancer	0.000542	0.00183	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—HEY1—pancreatic cancer	0.000542	0.00183	CbGpPWpGaD
Hydroxychloroquine—Nausea—Irinotecan—pancreatic cancer	0.00054	0.000795	CcSEcCtD
Hydroxychloroquine—Pain—Docetaxel—pancreatic cancer	0.000538	0.000791	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—PIK3CB—pancreatic cancer	0.000534	0.0018	CbGpPWpGaD
Hydroxychloroquine—Visual impairment—Doxorubicin—pancreatic cancer	0.000532	0.000783	CcSEcCtD
Hydroxychloroquine—Alopecia—Epirubicin—pancreatic cancer	0.000527	0.000776	CcSEcCtD
Hydroxychloroquine—Nausea—Gemcitabine—pancreatic cancer	0.000526	0.000774	CcSEcCtD
Hydroxychloroquine—Mental disorder—Epirubicin—pancreatic cancer	0.000523	0.000769	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000522	0.000768	CcSEcCtD
Hydroxychloroquine—Malnutrition—Epirubicin—pancreatic cancer	0.00052	0.000764	CcSEcCtD
Hydroxychloroquine—Nausea—Fluorouracil—pancreatic cancer	0.000517	0.000761	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—CCK—pancreatic cancer	0.000517	0.00175	CbGpPWpGaD
Hydroxychloroquine—Eye disorder—Doxorubicin—pancreatic cancer	0.000516	0.000759	CcSEcCtD
Hydroxychloroquine—Tinnitus—Doxorubicin—pancreatic cancer	0.000515	0.000758	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000514	0.000756	CcSEcCtD
Hydroxychloroquine—Tension—Epirubicin—pancreatic cancer	0.00051	0.00075	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—IFNA2—pancreatic cancer	0.000508	0.00172	CbGpPWpGaD
Hydroxychloroquine—Nervousness—Epirubicin—pancreatic cancer	0.000505	0.000742	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—CNR2—pancreatic cancer	0.000504	0.0017	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—GLP1R—pancreatic cancer	0.000504	0.0017	CbGpPWpGaD
Hydroxychloroquine—Body temperature increased—Docetaxel—pancreatic cancer	0.000497	0.000731	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Docetaxel—pancreatic cancer	0.000497	0.000731	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—CCKAR—pancreatic cancer	0.000496	0.00167	CbGpPWpGaD
Hydroxychloroquine—Vision blurred—Epirubicin—pancreatic cancer	0.00049	0.00072	CcSEcCtD
Hydroxychloroquine—Alopecia—Doxorubicin—pancreatic cancer	0.000488	0.000718	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—PIK3CD—pancreatic cancer	0.000484	0.00163	CbGpPWpGaD
Hydroxychloroquine—Mental disorder—Doxorubicin—pancreatic cancer	0.000484	0.000712	CcSEcCtD
Hydroxychloroquine—Malnutrition—Doxorubicin—pancreatic cancer	0.000481	0.000707	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—JAG2—pancreatic cancer	0.000481	0.00162	CbGpPWpGaD
Hydroxychloroquine—Anaemia—Epirubicin—pancreatic cancer	0.00048	0.000706	CcSEcCtD
Hydroxychloroquine—Agitation—Epirubicin—pancreatic cancer	0.000477	0.000702	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—MEN1—pancreatic cancer	0.000474	0.0016	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—CTNNB1—pancreatic cancer	0.000473	0.0016	CbGpPWpGaD
Hydroxychloroquine—Tension—Doxorubicin—pancreatic cancer	0.000472	0.000694	CcSEcCtD
Hydroxychloroquine—Nervousness—Doxorubicin—pancreatic cancer	0.000467	0.000687	CcSEcCtD
Hydroxychloroquine—Vertigo—Epirubicin—pancreatic cancer	0.000467	0.000687	CcSEcCtD
Hydroxychloroquine—Leukopenia—Epirubicin—pancreatic cancer	0.000465	0.000684	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000463	0.000681	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—BCL2L1—pancreatic cancer	0.000462	0.00156	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—PTEN—pancreatic cancer	0.000461	0.00156	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—TSC2—pancreatic cancer	0.000459	0.00155	CbGpPWpGaD
Hydroxychloroquine—Loss of consciousness—Epirubicin—pancreatic cancer	0.000457	0.000672	CcSEcCtD
Hydroxychloroquine—Vision blurred—Doxorubicin—pancreatic cancer	0.000453	0.000667	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—SHH—pancreatic cancer	0.000452	0.00153	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Docetaxel—pancreatic cancer	0.000451	0.000664	CcSEcCtD
Hydroxychloroquine—Convulsion—Epirubicin—pancreatic cancer	0.00045	0.000662	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—NOTCH4—pancreatic cancer	0.000449	0.00152	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IAPP—pancreatic cancer	0.000446	0.00151	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Docetaxel—pancreatic cancer	0.000445	0.000654	CcSEcCtD
Hydroxychloroquine—Anaemia—Doxorubicin—pancreatic cancer	0.000444	0.000654	CcSEcCtD
Hydroxychloroquine—Agitation—Doxorubicin—pancreatic cancer	0.000442	0.00065	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000439	0.000646	CcSEcCtD
Hydroxychloroquine—Vertigo—Doxorubicin—pancreatic cancer	0.000432	0.000635	CcSEcCtD
Hydroxychloroquine—Leukopenia—Doxorubicin—pancreatic cancer	0.00043	0.000633	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Docetaxel—pancreatic cancer	0.00043	0.000633	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—PTCH1—pancreatic cancer	0.000428	0.00145	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PTHLH—pancreatic cancer	0.000428	0.00145	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—SRC—pancreatic cancer	0.000428	0.00144	CbGpPWpGaD
Hydroxychloroquine—Oedema—Epirubicin—pancreatic cancer	0.000424	0.000624	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000423	0.000622	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—PIK3CB—pancreatic cancer	0.000422	0.00142	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—NFKBIA—pancreatic cancer	0.000419	0.00141	CbGpPWpGaD
Hydroxychloroquine—Convulsion—Doxorubicin—pancreatic cancer	0.000416	0.000613	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Epirubicin—pancreatic cancer	0.000416	0.000612	CcSEcCtD
Hydroxychloroquine—Dizziness—Docetaxel—pancreatic cancer	0.000416	0.000612	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000415	0.000611	CcSEcCtD
Hydroxychloroquine—Skin disorder—Epirubicin—pancreatic cancer	0.000412	0.000606	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—NRAS—pancreatic cancer	0.000411	0.00139	CbGpPWpGaD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000406	0.000598	CcSEcCtD
Hydroxychloroquine—Anorexia—Epirubicin—pancreatic cancer	0.000404	0.000595	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—EGF—pancreatic cancer	0.000401	0.00135	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Docetaxel—pancreatic cancer	0.0004	0.000588	CcSEcCtD
Hydroxychloroquine—Rash—Docetaxel—pancreatic cancer	0.000396	0.000583	CcSEcCtD
Hydroxychloroquine—Dermatitis—Docetaxel—pancreatic cancer	0.000396	0.000583	CcSEcCtD
Hydroxychloroquine—Headache—Docetaxel—pancreatic cancer	0.000394	0.000579	CcSEcCtD
Hydroxychloroquine—Oedema—Doxorubicin—pancreatic cancer	0.000392	0.000577	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—SST—pancreatic cancer	0.000392	0.00132	CbGpPWpGaD
Hydroxychloroquine—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000385	0.000566	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000384	0.000565	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—JAG1—pancreatic cancer	0.000383	0.00129	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NOTCH3—pancreatic cancer	0.000382	0.00129	CbGpPWpGaD
Hydroxychloroquine—Skin disorder—Doxorubicin—pancreatic cancer	0.000381	0.000561	CcSEcCtD
Hydroxychloroquine—Somnolence—Epirubicin—pancreatic cancer	0.000377	0.000555	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—EGFR—pancreatic cancer	0.000375	0.00127	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CTNNB1—pancreatic cancer	0.000374	0.00126	CbGpPWpGaD
Hydroxychloroquine—Anorexia—Doxorubicin—pancreatic cancer	0.000374	0.00055	CcSEcCtD
Hydroxychloroquine—Nausea—Docetaxel—pancreatic cancer	0.000373	0.000549	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—CDH1—pancreatic cancer	0.000373	0.00126	CbGpPWpGaD
Hydroxychloroquine—Decreased appetite—Epirubicin—pancreatic cancer	0.000369	0.000542	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000366	0.000539	CcSEcCtD
Hydroxychloroquine—Fatigue—Epirubicin—pancreatic cancer	0.000366	0.000538	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—BCL2L1—pancreatic cancer	0.000365	0.00123	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—PTEN—pancreatic cancer	0.000365	0.00123	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—TSC2—pancreatic cancer	0.000363	0.00123	CbGpPWpGaD
Hydroxychloroquine—Pain—Epirubicin—pancreatic cancer	0.000363	0.000533	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—CNR1—pancreatic cancer	0.000362	0.00122	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PIK3CD—pancreatic cancer	0.000357	0.0012	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—KRAS—pancreatic cancer	0.000354	0.0012	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—GCG—pancreatic cancer	0.000349	0.00118	CbGpPWpGaD
Hydroxychloroquine—Somnolence—Doxorubicin—pancreatic cancer	0.000349	0.000513	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000347	0.00051	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Doxorubicin—pancreatic cancer	0.000341	0.000502	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000339	0.000498	CcSEcCtD
Hydroxychloroquine—Fatigue—Doxorubicin—pancreatic cancer	0.000338	0.000498	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—SRC—pancreatic cancer	0.000338	0.00114	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Epirubicin—pancreatic cancer	0.000337	0.000496	CcSEcCtD
Hydroxychloroquine—Pain—Doxorubicin—pancreatic cancer	0.000335	0.000494	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Epirubicin—pancreatic cancer	0.000335	0.000493	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Epirubicin—pancreatic cancer	0.000335	0.000493	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—AGTR1—pancreatic cancer	0.000333	0.00113	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—NFKBIA—pancreatic cancer	0.000331	0.00112	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—STK11—pancreatic cancer	0.000328	0.00111	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—PIK3CA—pancreatic cancer	0.000325	0.0011	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—NRAS—pancreatic cancer	0.000325	0.0011	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000321	0.000472	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—EGF—pancreatic cancer	0.000317	0.00107	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000312	0.00046	CcSEcCtD
Hydroxychloroquine—Urticaria—Doxorubicin—pancreatic cancer	0.000312	0.000459	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—PIK3CB—pancreatic cancer	0.000311	0.00105	CbGpPWpGaD
Hydroxychloroquine—Abdominal pain—Doxorubicin—pancreatic cancer	0.00031	0.000456	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Doxorubicin—pancreatic cancer	0.00031	0.000456	CcSEcCtD
Hydroxychloroquine—Asthenia—Epirubicin—pancreatic cancer	0.000304	0.000448	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—HRAS—pancreatic cancer	0.000301	0.00102	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Epirubicin—pancreatic cancer	0.0003	0.000441	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—EGFR—pancreatic cancer	0.000296	0.001	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CDH1—pancreatic cancer	0.000295	0.000997	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Epirubicin—pancreatic cancer	0.00029	0.000427	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000289	0.000425	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—SMAD4—pancreatic cancer	0.000288	0.000971	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PIK3CD—pancreatic cancer	0.000282	0.000952	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Doxorubicin—pancreatic cancer	0.000281	0.000414	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—HES1—pancreatic cancer	0.000281	0.000948	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Epirubicin—pancreatic cancer	0.00028	0.000413	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—KRAS—pancreatic cancer	0.00028	0.000945	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Doxorubicin—pancreatic cancer	0.000278	0.000408	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—CTNNB1—pancreatic cancer	0.000276	0.000931	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Epirubicin—pancreatic cancer	0.00027	0.000397	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—PTEN—pancreatic cancer	0.000269	0.000907	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000268	0.000395	CcSEcCtD
Hydroxychloroquine—Rash—Epirubicin—pancreatic cancer	0.000267	0.000393	CcSEcCtD
Hydroxychloroquine—Dermatitis—Epirubicin—pancreatic cancer	0.000267	0.000393	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—AKT1—pancreatic cancer	0.000266	0.000897	CbGpPWpGaD
Hydroxychloroquine—Headache—Epirubicin—pancreatic cancer	0.000266	0.000391	CcSEcCtD
Hydroxychloroquine—Dizziness—Doxorubicin—pancreatic cancer	0.000259	0.000382	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—PIK3CA—pancreatic cancer	0.000257	0.000868	CbGpPWpGaD
Hydroxychloroquine—Nausea—Epirubicin—pancreatic cancer	0.000252	0.000371	CcSEcCtD
Hydroxychloroquine—Vomiting—Doxorubicin—pancreatic cancer	0.000249	0.000367	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—SRC—pancreatic cancer	0.000249	0.000841	CbGpPWpGaD
Hydroxychloroquine—Rash—Doxorubicin—pancreatic cancer	0.000247	0.000364	CcSEcCtD
Hydroxychloroquine—Dermatitis—Doxorubicin—pancreatic cancer	0.000247	0.000364	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—TERT—pancreatic cancer	0.000246	0.000831	CbGpPWpGaD
Hydroxychloroquine—Headache—Doxorubicin—pancreatic cancer	0.000246	0.000362	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—PIK3CB—pancreatic cancer	0.000246	0.00083	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—STAT3—pancreatic cancer	0.00024	0.000811	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—NRAS—pancreatic cancer	0.00024	0.000809	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—HRAS—pancreatic cancer	0.000238	0.000803	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—HIF1A—pancreatic cancer	0.000235	0.000795	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TSC2—pancreatic cancer	0.000235	0.000793	CbGpPWpGaD
Hydroxychloroquine—Nausea—Doxorubicin—pancreatic cancer	0.000233	0.000343	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—APOE—pancreatic cancer	0.00023	0.000776	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—KDR—pancreatic cancer	0.000225	0.00076	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—EGFR—pancreatic cancer	0.000218	0.000737	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CTNNB1—pancreatic cancer	0.000218	0.000736	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NFKBIA—pancreatic cancer	0.000214	0.000723	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PTEN—pancreatic cancer	0.000212	0.000717	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NOTCH1—pancreatic cancer	0.000212	0.000716	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—AKT1—pancreatic cancer	0.00021	0.000709	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CG—pancreatic cancer	0.000207	0.0007	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—KRAS—pancreatic cancer	0.000206	0.000696	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—EGF—pancreatic cancer	0.000205	0.000692	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—SRC—pancreatic cancer	0.000197	0.000665	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—STAT3—pancreatic cancer	0.00019	0.000641	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PIK3CA—pancreatic cancer	0.000189	0.00064	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—NRAS—pancreatic cancer	0.000189	0.00064	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CD—pancreatic cancer	0.000182	0.000615	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—HRAS—pancreatic cancer	0.000175	0.000592	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—EGFR—pancreatic cancer	0.000173	0.000583	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—KRAS—pancreatic cancer	0.000163	0.000551	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CB—pancreatic cancer	0.000159	0.000536	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—AKT1—pancreatic cancer	0.000155	0.000523	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CXCL8—pancreatic cancer	0.000153	0.000516	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PIK3CA—pancreatic cancer	0.00015	0.000506	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PRSS1—pancreatic cancer	0.000148	0.000501	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CASP3—pancreatic cancer	0.000146	0.000493	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CCND1—pancreatic cancer	0.000142	0.00048	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CTNNB1—pancreatic cancer	0.000141	0.000476	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—HRAS—pancreatic cancer	0.000139	0.000468	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MMP9—pancreatic cancer	0.000138	0.000466	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PTEN—pancreatic cancer	0.000137	0.000464	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ARG2—pancreatic cancer	0.000129	0.000434	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SRC—pancreatic cancer	0.000127	0.00043	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—VEGFA—pancreatic cancer	0.000124	0.000419	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—STAT3—pancreatic cancer	0.000123	0.000415	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NRAS—pancreatic cancer	0.000122	0.000414	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—AKT1—pancreatic cancer	0.000122	0.000413	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MYC—pancreatic cancer	0.000114	0.000385	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TGFB1—pancreatic cancer	0.000114	0.000384	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—TYMP—pancreatic cancer	0.000112	0.00038	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—EGFR—pancreatic cancer	0.000112	0.000377	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—KRAS—pancreatic cancer	0.000105	0.000356	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PIK3CA—pancreatic cancer	9.68e-05	0.000327	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TP53—pancreatic cancer	9.37e-05	0.000316	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GLP1R—pancreatic cancer	9.06e-05	0.000306	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—HRAS—pancreatic cancer	8.96e-05	0.000303	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—DPYD—pancreatic cancer	8.92e-05	0.000301	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	8.46e-05	0.000286	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—AKT1—pancreatic cancer	7.91e-05	0.000267	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CD44—pancreatic cancer	6.55e-05	0.000221	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GCG—pancreatic cancer	6.28e-05	0.000212	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—STK11—pancreatic cancer	5.91e-05	0.000199	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—TYMS—pancreatic cancer	5.08e-05	0.000172	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—APOE—pancreatic cancer	4.13e-05	0.00014	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	3.73e-05	0.000126	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PPARG—pancreatic cancer	3.6e-05	0.000122	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	3.28e-05	0.000111	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	2.86e-05	9.65e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	2.83e-05	9.56e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PTEN—pancreatic cancer	2.47e-05	8.34e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.74e-05	5.88e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.42e-05	4.81e-05	CbGpPWpGaD
